Point72 Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Point72 Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,377	Closed	-$57.3K	–	2958
2023 Q1	$57.3K	Buy	+2,377	New	+$29.8K	﹤0.01%	1758
2019 Q2	–	Sell	-56,751	Closed	-$131K	–	1607
2019 Q1	$131K	Hold	56,751	–	–	﹤0.01%	943
2018 Q4	$100K	Buy	+56,751	New	+$163K	﹤0.01%	909

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Point72 Asset Management's PRVB Position: Q2 2023 in Review

Point72 Asset Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 2,377 shares — an estimated $57.3K sold.

Point72 Asset Management first reported a position in PRVB in Q4 2018 and held it in 3 quarters. The position peaked at $131K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Point72 Asset Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Point72 Asset Management sold 2,377 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $57.3K.
Point72 Asset Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
Point72 Asset Management's Provention Bio, Inc. Common Stock position peaked at $131K in Q1 2019.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.